When was Somite founded?

Somite was founded in 2023 and raised its 1st funding round 1 year after it was founded.

Where is Somite located?

Somite is headquartered in Boston, United States.

Who is the current CEO of Somite?

Micha Y Breakstone of Somite. They have also founded 1 company.

How many employees does Somite have?

As of Mar 31, 2026, the latest employee count at Somite is 56.

Is Somite a funded company?

Somite is a funded company, having raised a total of $57.1M across 3 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Apr 16, 2024.

When was the latest funding round of Somite?

Somite's latest funding was a $***** Series A round on May 13, 2025, with participation from 8 investors. Its primary sector is Life Sciences Tech. In United States, the Life Sciences Tech sector has seen $1.94B in funding in 2026 to date.

Where does Somite rank among its competitors?

Somite ranks 9th amongst 161 active competitors, of which 65 are funded. It stands 8th in terms of total funding among its competitors. The most recent competitor to raise funding was Evotec, which secured an undisclosed amount in Jan, 2026.

Who are the top competitors of Somite?

Somite's top competitors include Evotec, Insitro and DNAnexus. Among them, Evotec secured the most recent funding round in January, 2026.

Somite - 2026 Company Profile, Team, Funding & Competitors

Company Details

AI-driven platform to produce human tissue for cell-based therapies. The company develops a digital twin of the embryo, a computational model simulating real embryo development to guide decision-making for generating cell-based therapies.

Website: somite.ai
Social
Email ID: *****@somite.ai

Key Metrics

Founded Year

2023

Location

Boston, United States

Stage

Series A

Total Funding

$57.1M in 3 rounds

Latest Funding Round

Series A, May 13, 2025, $*****

Investors

Khosla Ventures & 14 more

Ranked

9^th among 161 active competitors

Employee Count

56 as on Mar 31, 2026

Similar Companies

Evotec & 185 more

View Somite's full profile

Somite has raised a total funding of $57.1M over 3 rounds. Its first funding round was on Apr 16, 2024. Its latest funding round was a Series A round on May 13, 2025 for $*****. 8 investors participated in its latest round. Somite has 12 institutional investors and 3 angel investors.

Here is the list of recent funding rounds of Somite:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
May 13, 2025	2008690	Series A	7397907	7811363	2451272	2086204
Sep 03, 2024	7666661	Seed	9442124	9488888	1779369	6330960
Apr 16, 2024	1081950	Seed	8100670	9063416	2818343	TechAviv & 4 more

Access funding benchmarks and valuations. Sign up today!

View details of Somite's funding rounds and investors

The founders of Somite are Micha Y Breakstone, Jay Shendure, Olivier Pourquie, Cliff Tabin, Allon Klein and Jonathan Rosenfeld. Micha Y Breakstone is the CEO of Somite.

Here are the details of Somite's key team members:

Micha Y Breakstone: Co-Founder & CEO of Somite and founder of 2 other companies, Neuralight and Chorus.ai.
Contact Info: 1 email address
Jay Shendure: Co-Founder of Somite.
Contact Info: 1 email address
Olivier Pourquie: Co-Founder of Somite.
Contact Info: 1 email address
Cliff Tabin: Co-Founder of Somite.
Contact Info: 1 email address
Allon Klein: Co-Founder of Somite.
Contact Info: 1 email address

View details of Somite's Founder profiles and Board Members

Somite's employee count trend

Somite has 56 employees as of Mar 26. Here is Somite's employee count trend over the years:

Uncover Somite's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Somite include Evotec, Insitro and DNAnexus. Here is the list of Top 10 competitors of Somite, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Evotec 1993, Hamburg (Germany), Public	Provider of drug discovery alliance and development services for biopharma sector	$25M	TVM Capital Life Science, Omega Funds & 21 others	74/100
2nd	Insitro 2018, San Francisco (United States), Series C	Developer of machine learning platform for drug discovery and development	$643M	Andreessen Horowitz, Google Ventures & 18 others	70/100
3rd	DNAnexus 2009, Mountain View (United States), Series H	Provider of cloud-based genome informatics & data management platform	$473M	Google Ventures, TPG & 21 others	70/100
4th	Immunai Technologies 2018, United States, Series B	Developer of next-generation of immunomodulatory therapeutics	$295M	Viola Group, TLV Partners & 14 others	66/100
5th	Asimov 2017, Boston (United States), Series B	Provider of integrated suite for advanced genetic design and manufacturing	$237M	Andreessen Horowitz, CPP Investments & 11 others	65/100
6th	Metagenomi 2016, Berkeley (United States), Public	Digital gene editing technologies for drug development	$376M	Humboldt Fund, RA Capital Management & 22 others	65/100
7th	Cytel 1987, Cambridge (United States), Acquired	Provider of data analysis and statistical solutions for the life sciences industry	$2M	Autonomy Ventures, Merck & 3 others	65/100
8th	NewLimit 2022, San Francisco (United States), Series B	Developer of epigenetic reprogramming medicines for aging-related diseases and healthspan extension	$247M	Kleiner Perkins, Lilly & 17 others	64/100
9th	Somite 2023, Boston (United States), Series A	AI-driven platform to produce human tissue for cell-based therapies	$57.1M	Astellas Venture Management, Khosla Ventures ... & 13 others	64/100
10th	Relation 2019, London (United Kingdom), Seed	AI-based drug development tools for researchers	$116M	DCVC, Magnetic Ventures & 9 others	64/100